Bausch Health
347 hedge funds and large institutions have $4.5B invested in Bausch Health in 2016 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 127 increasing their positions, 107 reducing their positions, and 94 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 107
11% less funds holding
Funds holding: 389 → 347 (-42)
14.43% less ownership
Funds ownership: 79.5% → 65.07% (-14%)
15% less funds holding in top 10
Funds holding in top 10: 27 → 23 (-4)
20% less call options, than puts
Call options by funds: $814M | Put options by funds: $1.02B
37% less capital invested
Capital invested by funds: $7.19B → $4.5B (-$2.69B)
40% less first-time investments, than exits
New positions opened: 56 | Existing positions closed: 94
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$286M |
| 2 |
PC
Paulson & Co
New York
|
+$164M |
| 3 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$70.8M |
| 4 |
H
Hexavest
Montreal,
Quebec, Canada
|
+$46.8M |
| 5 |
HT
HAP Trading
New York
|
+$39.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCG
Ruane, Cunniff & Goldfarb
New York
|
-$846M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$205M |
| 3 |
Eagle Capital Management (New York)
New York
|
-$166M |
| 4 |
HP
Hound Partners
New York
|
-$130M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$96.7M |
BHC Hedge Fund Activity: Q2 2016 in Review
347 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2016, worth a combined $4.5B — down 37% from $7.19B a quarter earlier.
Sellers outnumbered buyers: 94 funds closed out of BHC and 56 opened new positions — a net loss of 38 holders — while 107 trimmed existing stakes and 127 added.
The largest buyer was Fidelity Investments, adding an estimated $286M. The largest seller was Ruane, Cunniff & Goldfarb, cutting an estimated $846M.
- 347 institutional investors held Bausch Health (BHC) as of Q2 2016, down from 389 in Q1 2016.
- Funds reported $4.5B of Bausch Health stock for Q2 2016, down 37% quarter-over-quarter.
- 56 funds opened new Bausch Health positions in Q2 2016 and 94 closed out, a net change of -38 holders.
- The largest Bausch Health buyer in Q2 2016 was Fidelity Investments, an estimated $286M added.
- The largest Bausch Health seller in Q2 2016 was Ruane, Cunniff & Goldfarb, an estimated $846M sold.
Based on aggregated 13F filings for Q2 2016.